Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 9.57
-0.06 (-0.62%)
Jul 25, 2025, 5:00 PM CET
Mabion Company Description
Mabion S.A., a biotechnology company, provides services for the contract development and manufacturing of biologic medicines in Poland.
The company offers clinical and commercial drug substance manufacturing of therapeutic proteins using mammalian and insect cell cultures, including biosimilars, monoclonals, other therapeutic proteins, recombinant vaccine antigens, and other recombinant proteins.
Its products include MabionCD20 and other products. Mabion S.A. was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.
Mabion S.A.
| Country | Poland |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 213 |
| CEO | Krzysztof Kaczmarczyk |
Contact Details
Address: ul. gen. Mariana Langiewicza 60 Konstantynów Lódzki, 95-050 Poland | |
| Phone | 48 42 207 7890 |
| Website | mabion.eu |
Stock Details
| Ticker Symbol | MAB |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLMBION00016 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Krzysztof Kaczmarczyk | Chief Executive Officer and President of Management Board |
| Grzegorz Grabowicz | Chief Financial Officer, Financial Director and Member of Management Board |
| Dr. Slawomir Jaros EMBA, Eng., Ph.D. | Member of the Management Board and Scientific and Quality Director |
| Adam Pietruszkiewicz | Member of Management Board and Business Development Director |
| Julita Balcerek M.D. | Member of the Management Board, Operations Director and Chief Operating Officer |
| Aneta Turek | Chief Accountant |
| Pawel Pobiedzinski | Head of Logistics and Procurement |
| Joanna Krolasik | Head of Microbiology Laboratory |